News
12-10-2010, 05:53 AM
Nektar Therapeutics today announced that new Phase 2 clinical data from its study of single-agent NKTR-102 in metastatic breast cancer patients will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas on December 12, 2010.
More... (http://www.news-medical.net/news/20101210/Nektars-new-NKTR-102-Phase-2-data-in-metastatic-breast-cancer-to-be-presented-at-33rd-CTRC-AACR-SABCS.aspx)
More... (http://www.news-medical.net/news/20101210/Nektars-new-NKTR-102-Phase-2-data-in-metastatic-breast-cancer-to-be-presented-at-33rd-CTRC-AACR-SABCS.aspx)